Retrospective Study to Determine Factors Influencing Outcome in Patients With Human Epidermal Growth Factor Receptor 2–Positive Breast Cancer Receiving Neoadjuvant Chemotherapy

Retrospective Study to Determine Factors Influencing Outcome in Patients With Human Epidermal Growth Factor Receptor 2–Positive Breast Cancer Receiving Neoadjuvant Chemotherapy

PURPOSEThere are scant data on patients with human epidermal growth factor receptor 2 (HER2)–positive breast cancer treated with neoadjuvant therapy (NAT) in real-world settings with limited access to HER2-targeted therapy.METHODSThis was a retrospective analysis of patients with nonmetastatic, HER2...

Full description

Saved in:
Bibliographic Details
Main Authors: Minit Shah, Sushmita Rath, Seema Gulia, Prabhat Bhargava, Anbarasan Sekar, Swapnil Rane, Jyoti Bajpai, Tanuja Shet, Sangeeta Desai, Rajiv Sarin, Rima Pathak, Palak Popat, Pallavi Parab, Yogesh Kembhavi, Dinesh Jethwa, Snigdha Dutta, Asawari Patil, Nita Nair, Pallavi Rane, Ankush Shetake, Manali Kolkur, Shalaka Joshi, Rajendra A. Badwe, Sudeep Gupta
Format: Article
Language:English
Published: American Society of Clinical Oncology 2025-04-01
Series:JCO Global Oncology
Online Access:https://ascopubs.org/doi/10.1200/GO-24-00365
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://ascopubs.org/doi/10.1200/GO-24-00365

Similar Items